Evidence map›Paper›PMID 36219361›Full record

ReviewNeurosurgical review2022

Molecular and genetic mechanisms in brain arteriovenous malformations: new insights and future perspectives.

Sandra Vetiska, Thomas Wälchli, Ivan Radovanovic, Moncef Berhouma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurosurgical review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Sandra VetiskaKrembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
Thomas WälchliKrembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
Ivan RadovanovicKrembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
Moncef BerhoumaDepartment of Neurosurgery, University Hospital of Dijon Bourgogne, Dijon, France. berhouma.moncef@gmail.com.
Maison des Sciences de l’Homme de Dijon · FRToronto Western Hospital · CAUniversity Health Network · CAUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain arteriovenous malformations (bAVMs) are rare vascular lesions made of shunts between cerebral arteries and veins without the interposition of a capillary bed. The majority of bAVMs are asymptomatic, but some may be revealed by seizures and potentially life-threatening brain hemorrhage. The management of unruptured bAVMs remains a matter of debate. Significant progress in the understanding of their pathogenesis has been made during the last decade, particularly using genome sequencing and biomolecular analysis. Herein, we comprehensively review the recent molecular and genetic advances in the study of bAVMs that not only allow a better understanding of the genesis and growth of bAVMs, but also open new insights in medical treatment perspectives.

Indexed as

Intracranial Arteriovenous MalformationsBrainCerebral ArteriesHumansIntracranial HemorrhagesAngiogenesisBrain arteriovenous malformationsGeneticsPathogenesis, Vasculogenesis

Identifiers

PMID36219361
OpenAlexW4304190351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.